Contact Us
Molnunat 200mg Tablet (Molnupiravir Tablets)

Molnunat 200mg Tablet (Molnupiravir Tablets)

200mg Tablet, Bottle

4.5 (154)

₹1,300

Molnunat 200mg Tablet is an oral antiviral medication used to treat mild to moderate COVID-19 in adults, particularly those at high risk of severe illness (such as due to obesity, older age, diabetes, or heart disease). It works by inhibiting the SARS-CoV-2 virus from replicating, reducing viral load and disease severity. It received emergency use approval from Indian, US, and UK regulatory authorities, and is not intended for patients requiring immediate hospitalization due to COVID-19.

Request a Quote

MedlinePlus Drug Information

  • Free shipping on orders over $10000!
  • No-Risk Money Back Guarantee!
  • No Hassle Refunds
Description

Introduction Of Molnunat 200mg Tablets:

Molnunat 200mg Tablet is the principal oral antiviral medicine that helps treat gentle to direct COVID-19 in grown-ups. It keeps the infection from duplicating, subsequently decreasing viral burden and sickness seriousness. The medication got crisis use endorsement from Indian medication administrative experts on December 28, 2021.

Molnunat 200mg Tablet is just shown in patients with gentle to direct COVID-19 side effects and who have a high gamble of creating extreme side effects. The gamble factors incorporate weight, more established age (>60 years), diabetes mellitus, and heart illnesses. Not showed in patients require quick hospitalization because of COVID-19. This medication has likewise been endorsed by the U.S. Food and Drug Administration (FDA) and the UK administrative organization for crisis use.

Uses Of Molnunat 200mg Tablets:

  • Treatment of Mild to Direct Coronavirus Sickness (COVID-19)

Mechanism Of Action Of Molnunat 200mg Tablets:

Molnunat 200mg Tablet is an antiviral medication. It works by restraining the SARS-CoV-2 infection from duplicating. This prevents the infection from delivering new duplicates and consequently diminishes the viral burden in the body.

Contact Us

Category
Info Table
Brand Name Molnunat 200mg Tablet
Manufacturer natco
Packaging Size 40 tablets in 1 bottle
Composition Molnupiravir 200mg
Usage/Application Treatment of Mild to moderate Coronavirus disease
Country of Origin Made in India
Vendor Info
Benefits
Reviews

Description

Introduction Of Molnunat 200mg Tablets:

Molnunat 200mg Tablet is the principal oral antiviral medicine that helps treat gentle to direct COVID-19 in grown-ups. It keeps the infection from duplicating, subsequently decreasing viral burden and sickness seriousness. The medication got crisis use endorsement from Indian medication administrative experts on December 28, 2021.

Molnunat 200mg Tablet is just shown in patients with gentle to direct COVID-19 side effects and who have a high gamble of creating extreme side effects. The gamble factors incorporate weight, more established age (>60 years), diabetes mellitus, and heart illnesses. Not showed in patients require quick hospitalization because of COVID-19. This medication has likewise been endorsed by the U.S. Food and Drug Administration (FDA) and the UK administrative organization for crisis use.

Uses Of Molnunat 200mg Tablets:

  • Treatment of Mild to Direct Coronavirus Sickness (COVID-19)

Mechanism Of Action Of Molnunat 200mg Tablets:

Molnunat 200mg Tablet is an antiviral medication. It works by restraining the SARS-CoV-2 infection from duplicating. This prevents the infection from delivering new duplicates and consequently diminishes the viral burden in the body.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Molnunat 200mg Tablet (Molnupiravir Tablets)”

Your email address will not be published. Required fields are marked *

  • Faq

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Molnunat 200mg Tablet used for?
Molnunat 200mg Tablet is an oral antiviral medicine used to treat mild to moderate COVID-19 in adults at high risk of severe illness, including those with obesity, older age, diabetes, or heart disease.
It inhibits the SARS-CoV-2 virus from replicating, which prevents the virus from producing new copies of itself and reduces the overall viral load and disease severity in the body.
It’s not indicated for patients who require immediate hospitalization due to COVID-19. It’s also not recommended for use during pregnancy, since safety data in pregnant patients remains limited.
It received emergency use approval from Indian drug regulatory authorities on December 28, 2021, and has also been authorized for emergency use by the U.S. FDA and the UK regulatory agency.
Risk factors include obesity, older age (over 60 years), diabetes mellitus, and heart disease. Molnunat is specifically indicated for these higher-risk patients with mild to moderate symptoms.
Given its role as an emergency-use antiviral requiring risk assessment before starting, Molnunat should only be taken under a doctor’s guidance and prescription, not used independently.

Related products

Explore More
Bryxta 400mg Bevacizumab Injection

Bryxta 400mg Bevacizumab Injection

Vial

View Product
Vanlid 250mg Capsules

Vanllid Vancomycin 250mg Capsules

250mg Capsule, Box

View Product
Endogest 200mg Capsule

Progesterone (Endogest 200mg)

200mg Capsule, Stripe

View Product
Ematra 10 Mg Softgel Capsules (Ematra Capsule)

Ematra 10 Mg Softgel Capsules (Ematra Capsule)

10mg Capsules, Box

View Product
Let's chat